Clinical-stage immuno-oncology developing CyPep-1 tumor immunotherapy
| Date | Round | Amount |
|---|---|---|
| Jun 2023 | Series A Bergen immuno-oncology startup Cytovation added $8M (NOK85M) to its Series A, now over $28M total. | $8M |
| Feb 2022 | Series A Bergen oncology biotech Cytovation raised a 180M kroner (17.69M euro) Series A led by Sandwater and Canica. | $17.7M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.